* Thorne Healthtech Inc THRN.OQ reported quarterly
adjusted
earnings of 7 cents per share for the quarter ended in
September. The mean expectation of three analysts for the
quarter was for earnings of 14 cents per share.
* Revenue rose 21.7% to $58.42 million from a year ago;
analysts
expected $63.44 million.
* Thorne Healthtech Inc's reported EPS for the quarter was 7
cents.
* The mean earnings estimate of analysts had risen by
about 64.7%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Thorne Healthtech Inc shares had risen by 2.1% this
quarter and
lost 22.2% so far this year.
* The company reported quarterly net income of $3.74
million.
* Wall Street's median 12-month price target for Thorne
Healthtech
Inc is $8.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data November
9 at 11:25 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2022 0.14 0.07 Missed
Jun. 30 2022 0.00 -0.11 Missed
Mar. 31 2022 0.10 0.09 Missed
Dec. 31 2021 0.03 0.06 Beat